Opko Health, Inc. (NASDAQ:OPK) registered a -1.39% decrease, still its new closing price is 14.69% up from the company’s 1 year high of 12.15.It posted -2.41% losses in previous 5 sessions and is now the subject of 1 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 1 buy or better ratings. The 5 stock analysts following this company have an average price target at $15.50, with individual PT in the $10.00-$19.50 range. The shares moved at $8.51, implying that brokerage firms see shares gaining about 9.24% in twelve months time.
Opko Health, Inc. (OPK) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a -8.49% fall year to date. A CEO & Chairman, 10% Owner at Opko Health, Inc. (OPK) acquired shares in a transaction closed on Wednesday February 01, 2017. FROST PHILLIP MD ET AL bought 9,000 shares in the company at $8.59 each and collected $77,000 in proceeds. FROST PHILLIP MD ET AL now owns 183,711,956 shares in the company after this transaction. A CEO & Chairman, 10% Owner in the company, FROST PHILLIP MD ET AL, disclosed a transaction on Tuesday January 31, 2017 that ended up paying $103,000 from the purchase of 12,000 shares at $8.6 per share.
Opko Health, Inc. (NASDAQ:OPK) Upcoming Results on Tap
Opko Health, Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $-0.02 in that period. Sales during the quarter are predicted to arrive at $323.05 million.
Earnings surprise history: Last quarter, the company posted approximately $298.04 million in revenue and EPS of $-0.03. The mean forecast was for $322 million and $-0.03 a share, respectively. One quarter earlier, revenue for the stock was at $357.1 million, with earnings at $0.02/share.
Opko Health, Inc. (OPK) Brokerage Update
Opko Health, Inc. (OPK) is in Jefferies’s research list so their analyst rating change is noteworthy. These shares were downgraded to Hold from Buy by Jefferies, according to news reported on Friday September 11, 2015.Another important research note was issued by Oppenheimer on Tuesday March 03, 2015.The firm downgraded OPK to Perform from Outperform. Over the last six months and over the last three months, the shares of Opko Health, Inc. (OPK), have changed -14.73% and -10.98%, respectively.